Ophthalmic formulations of cetirizine and methods of use
    2.
    发明授权
    Ophthalmic formulations of cetirizine and methods of use 有权
    西替利嗪的眼用制剂及其使用方法

    公开(公告)号:US08569273B2

    公开(公告)日:2013-10-29

    申请号:US12888117

    申请日:2010-09-22

    IPC分类号: A61K31/56 A61P27/14

    摘要: The present invention provides stable topical formulations of cetirizine that provide a comfortable formulation when instilled in the eye and is effective in the treatment of allergic conjunctivitis and/or allergic conjunctivitis. The invention further provides methods of treating allergic conjunctivitis rhinitis, and/or allergic rhinoconjunctivitis in a subject in need of such treatment by topical application of the cetirizine formulations of the invention directly to the eye.

    摘要翻译: 本发明提供了西替利嗪的稳定的局部制剂,其在滴注在眼睛中时提供舒适的制剂,并且有效治疗过敏性结膜炎和/或过敏性结膜炎。 本发明进一步提供了通过将本发明的西替利嗪制剂直接局部施用于眼睛来治疗需要这种治疗的受试者的过敏性结膜炎鼻炎和/或过敏性鼻结膜炎的方法。

    Ophthalmic Formulations Of Cetirizine And Methods Of Use
    3.
    发明申请
    Ophthalmic Formulations Of Cetirizine And Methods Of Use 有权
    西替利嗪的眼科配方及其使用方法

    公开(公告)号:US20110257136A1

    公开(公告)日:2011-10-20

    申请号:US12888117

    申请日:2010-09-22

    IPC分类号: A61K31/56 A61P27/14

    摘要: The present invention provides stable topical formulations of cetirizine that provide a comfortable formulation when instilled in the eye and is effective in the treatment of allergic conjunctivitis and/or allergic conjunctivitis. The invention further provides methods of treating allergic conjunctivitis rhinitis, and/or allergic rhinoconjunctivitis in a subject in need of such treatment by topical application of the cetirizine formulations of the invention directly to the eye.

    摘要翻译: 本发明提供了西替利嗪的稳定的局部制剂,其在滴注在眼睛中时提供舒适的制剂,并且有效治疗过敏性结膜炎和/或过敏性结膜炎。 本发明进一步提供了通过将本发明的西替利嗪制剂直接局部施用于眼睛来治疗需要这种治疗的受试者的过敏性结膜炎鼻炎和/或过敏性鼻结膜炎的方法。